Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Endologix Inc (ELGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 72,415
  • Shares Outstanding, K 103,450
  • Annual Sales, $ 181,160 K
  • Annual Income, $ -66,400 K
  • 36-Month Beta 0.37
  • Price/Sales 0.39
  • Price/Cash Flow N/A
  • Price/Book 1.34
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.57
  • Most Recent Earnings -0.12 on 11/01/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.20
  • Number of Estimates 5
  • High Estimate -0.14
  • Low Estimate -0.26
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -150.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.65 +0.11%
on 12/17/18
1.04 -37.43%
on 11/19/18
-0.37 (-36.21%)
since 11/16/18
3-Month
0.65 +0.11%
on 12/17/18
2.20 -70.42%
on 10/03/18
-1.17 (-64.25%)
since 09/17/18
52-Week
0.65 +0.11%
on 12/17/18
6.72 -90.32%
on 06/15/18
-4.60 (-87.61%)
since 12/15/17

Most Recent Stories

More News
Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Endologix, Inc.(Nasdaq: ELGX) (the "Company"), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of inducement equity awards to three newly...

ELGX : 0.65 (-7.14%)
Endologix Honors Innovators of Aortic Therapy at VEITHsymposium

Endologix, Inc. (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today honored four innovators of aortic therapy at the 45th Annual Symposium on Vascular...

ELGX : 0.65 (-7.14%)
Report: Developing Opportunities within Mednax, Peabody Energy, NIC, Endologix, MobileIron, and QuinStreet -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Mednax, Inc (NYSE:MD), Peabody...

BTU : 31.35 (+2.85%)
MD : 35.97 (-0.77%)
ELGX : 0.65 (-7.14%)
MOBL : 4.41 (-2.65%)
QNST : 15.80 (-0.82%)
EGOV : 12.27 (-0.89%)
Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Endologix, Inc.(Nasdaq: ELGX) (the "Company"), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of inducement equity awards to three newly...

ELGX : 0.65 (-7.14%)
Endologix (ELGX) Reports Q3 Loss, Tops Revenue Estimates

Endologix (ELGX) delivered earnings and revenue surprises of 40.00% and 9.30%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

ELGX : 0.65 (-7.14%)
Endologix: 3Q Earnings Snapshot

IRVINE, Calif. (AP) _ Endologix Inc. (ELGX) on Thursday reported a loss of $10.1 million in its third quarter.

ELGX : 0.65 (-7.14%)
Endologix Reports Third Quarter 2018 Financial Results

Endologix, Inc. (the "Company") (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the third quarter ended September30,...

ELGX : 0.65 (-7.14%)
Endologix, Inc. to Present at Two Investor Conferences in November

Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will present at the following two investor conferences in November:...

ELGX : 0.65 (-7.14%)
Endologix Announces Pricing of Public Offering of Common Stock

Endologix, Inc. (Nasdaq: ELGX) ("Endologix" or the "Company"), developer and marketer of innovative treatments for aortic disorders, announced today the pricing of a registered underwritten...

ELGX : 0.65 (-7.14%)
Endologix Announces Public Offering of Common Stock

Endologix, Inc. (Nasdaq:ELGX) ("Endologix" or the "Company"), developer and marketer of innovative treatments for aortic disorders, announced today that it has commenced a registered underwritten...

ELGX : 0.65 (-7.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ELGX with:

Business Summary

Endologix, Inc. develops, manufactures and markets products for the treatment of coronary and vascular diseases. A leader in the emerging field of vascular brachytherapy, Endologix, has developed a unique method for the delivery of radiation to prevent restenosis following the interventional treatment...

See More

Key Turning Points

2nd Resistance Point 0.79
1st Resistance Point 0.74
Last Price 0.65
1st Support Level 0.66
2nd Support Level 0.63

See More

52-Week High 6.72
Fibonacci 61.8% 4.40
Fibonacci 50% 3.68
Fibonacci 38.2% 2.97
Last Price 0.65
52-Week Low 0.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar